SOTIO Biotech is a Czech biotechnology company focused on clinical-stage research and development of innovative medicines for cancer with operations in Europe, North America, and Asia. The company has clinical programs which include a superagonist of the immuno-oncology target IL-15, a new generation of potent and stable antibody-drug conjugates (ADCs), proprietary technology designed to improve on the efficacy of CAR T therapies and a platform to streamline and enhance personalized cell therapies. The company was founded in 2010 and in 2012 became part of PPF Group, owned by Petr Kellner. The CEO of the company is Radek Špíšek, who has been with the company since its beginning, initially functioning as Chief Scientific Officer. More information...
According to PR-model, sotio.com is ranked 1,035,351st in multilingual Wikipedia, in particular this website is ranked 652,190th in English Wikipedia.
The website is placed before visitburbank.com and after evenfallstudios.com in the BestRef global ranking of the most important sources of Wikipedia.
